Marshall Wace’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.71M	Buy	2,376,304 +1,113,937	+88%	+$1.62M	﹤0.01%	1451
2025 Q4	$1.45M	Buy	+1,262,367	New	+$1.73M	﹤0.01%	1752
2024 Q4	–	Sell	-574,150	Closed	-$901K	–	2829
2024 Q3	$901K	Sell	574,150 -616,298	-52%	-$1.1M	﹤0.01%	1689
2024 Q2	$2M	Buy	1,190,448 +691,276	+138%	+$1.24M	﹤0.01%	1369
2024 Q1	$1.2M	Buy	+499,172	New	+$1.07M	﹤0.01%	1581
2023 Q3	–	Sell	-125,287	Closed	-$287K	–	2483
2023 Q2	$287K	Buy	+125,287	New	+$333K	﹤0.01%	2155
2020 Q4	–	Sell	-281,647	Closed	-$406K	–	2057
2020 Q3	$406K	Sell	281,647 -654,944	-70%	-$1.17M	﹤0.01%	1288
2020 Q2	$1.87M	Sell	936,591 -409,019	-30%	-$801K	0.01%	816
2020 Q1	$2.62M	Buy	1,345,610 +494,682	+58%	+$1.47M	0.03%	540
2019 Q4	$3.53M	Buy	+850,928	New	+$3.28M	0.02%	646
2019 Q1	–	Sell	-264,139	Closed	-$1.75M	–	1917
2018 Q4	$1.75M	Buy	264,139 +229,876	+671%	+$1.86M	0.02%	763
2018 Q3	$366K	Sell	34,263 -616,555	-95%	-$7.06M	﹤0.01%	990
2018 Q2	$7.81M	Sell	650,818 -85,727	-12%	-$877K	0.12%	211
2018 Q1	$6.31M	Buy	+736,545	New	+$6.81M	0.26%	92
2015 Q3	–	Sell	-12,945	Closed	-$104K	–	1007
2015 Q2	$104K	Sell	12,945 -63,724	-83%	-$468K	﹤0.01%	855
2015 Q1	$507K	Buy	+76,669	New	+$524K	0.01%	668

Other funds holding LXRX